NASDAQ:BIIB
Biogen Idec Inc.
(NASDAQ:BIIB)
291.71
-1.49
(-0.51%)
As of 2021-09-24 Close (EST)
| 52 Week Rng | - |
| Market Cap | - |
| Avg Volume | - |
| 1M Volatility | - |
| Short Ratio | - |
| P/E Ratio (TTM) | - |
| P/E Ratio (Fwd) | - |
| P/B Ratio | - |
| Div & Yield | - |
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
caitlinsheng • Abington 2021 • Apr 2021
New experimental ALS medicine could be revolutionary
ACTION
TICKER
SHARES
STATUS
InvestmentTeam2 • Stockfuse Continuum (US) • Apr 2021
Closing all the open orders from the investment game.
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
InvestmentTeam2 • BU52043 Investment Game 2020/21 • Feb 2021
A best value stock. Company focuses on discovery, development and commercialization of pharmaceutical treatments with a strong focus on neurology, oncology and immunology. Has a PE ratio of 9.1
ACTION
TICKER
SHARES
STATUS